Editas Medicine, Inc.

EDIT

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001650664-26-000009
Filing date: Mar 4, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: O'Neill Gilmore Neil (CEO)

Summary

Type

Sell

Net shares

-5,394

% of shares

-2.00%

Amount (USD)

$10,894

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-5,394.0

Price per Share

$2.02

Amount (USD)

$10,894.26

Acquired/Disposed

Disposed

Shares Owned Before

269,087.0

Shares Owned After

263,693.0

Filing's footnotes

1. Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

2. This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204 The price reported above reflects the weighted average purchase price. The Reporting Person herebyundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.